10 May 2022

Profile on…
Sir Michael

Recognising the individuals and organisations behind some of Cambridge’s greatest creations and discoveries, In Search of Wonder® celebrates innocent curiosity and the power of innovation. That’s why we partnered with the Cambridge Independent to sponsor their Lifetime Achievement award at the Science and Tech awards.

Now we have the honour of announcing the inaugural recipient - the world-renowned clinical scientist… Sir Michael Stratton.

Sequencing the cancer genome

The human genome. The biological set of instructions that make us, us. A mind-blowing collection of 3.2 billion DNA bases, derived from 23 pairs of chromosomes. Formed of the 20,000 gene patterns that make a person unique. Perfectly replicated in each of the trillions of cells in our body, the information included within responsible for making us grow, develop and, ultimately, stay alive.

In short, it’s a fascinating and complex thing.

Our inaugural lifetime achievement award recipient certainly thinks so – he’s dedicated his life to exploring it, after all. And thanks to the work of him and his team at the Wellcome Sanger Institute, we have successfully sequenced parts of this information and used it to save and prolong countless lives.

Here we learn more about the award recipient: Sir Michael Stratton.

Sir Michael Stratton – From ward to lab

Graduating from Brasenose College, Oxford with a degree in medicine in 1979, Stratton’s career started on hospital wards, but soon transferred to the lab. Following early experiences as a junior doctor at Guy’s Hospital, London, a fascination with cancer genetics led him to undertake further training to become a histopathologist – an expert doctor who studies cellular samples under a microscope.

Fuelled by his curiosity, Stratton wanted to discover more about what makes the human body work as it does. Speaking to yourgenome.org about his early career, he said: “peering into this hidden world provides you with profound and powerful insights into the ways disease is generated… there is sometimes awful beauty in the way cells conspire to orchestrate life-threatening conditions”.

Eleven years later, he would complete his PhD, researching the molecular biology of cancer at London’s Institute of Cancer Research (ICR) and accept a role at the same organisation.

This is where it gets interesting.

While at the ICR, Stratton and his team worked day and night to identify BRCA2 (Breast Cancer 2) – a gene that, if mutated, significantly increases the risk of breast cancer in men and women. When working correctly, the BRCA2 gene actually helps our bodies to repair damaged DNA, so any genetic mutations that inhibit its function can lead to an increased chance of developing cancer.

This discovery was in December 1995.

Since then, this learning has led to new innovations in cancer testing, prevention and treatment. We now know that mutations in BRCA2 lead to increased risks of ovarian, Fallopian tube, prostate and pancreatic cancers. This knowledge means people with a family history of breast and ovarian cancer can have access to genetic screening that will identify if they too have a faulty BRCA1 or BRCA2 gene. Those that do can then monitor changes through regular breast screening, have surgery to remove the breasts or ovaries, or use preventative drugs to lower the cancer risk.

This has played a big part in the reduction of deaths from breast cancer in recent years.

But it’s only the start of Stratton’s achievements.

The Cancer Genome Project – Further breakthrough discoveries

In 2000, Sir Stratton moved to Cambridge to join the Wellcome Sanger Institute. Already a large player in the international Human Genome Project – an ambitious piece of research to map and sequence all of the genes in the human genome – the institute was at the forefront of genomics and continues to push boundaries to this day.

Stratton could immediately see the benefits for his own field, and it was here that he introduced the Cancer Genome Project with an ambitious aim: to identify all cancer genes.

The project has been a success.

In 2002, he and his team discovered mutations in the BRAF gene, which can be found in 60% of malignant melanomas. Nowadays BRAF inhibiting drugs have led to improved survival rates as a direct result of this research.

By 2020, over 800 cancer genes had been identified through Sanger scientists, and others around the world.

More recently working as one of the lead researchers on the International Cancer Genome Project – a worldwide collaboration studying cancer genomes in 50 different cancer types – Stratton has continued to advance our understanding of the causes of cancers enabling us to discover more ways to prevent and treat them.

Darwin Tree of Life – The most ambitious challenge

The next step for Stratton and the Wellcome Sanger Institute is their most ambitious yet – sequencing all of life.

Speaking of this project at the Science and Tech Awards, Stratton said:

“Possibly the most ambitious challenge that we are getting ready to address is sequencing all the different species on earth i.e. all of life. There are probably about 2 million species, or there are 2 million species that we know the names of, and almost certainly many many others. And we will start in that endeavour by sequencing the 70,000 species which exist in the UK and Ireland in a project which we call the Darwin Tree of Life.

“And in this way, we as human beings will justify our status, not just as another species,  but as custodians of life on Earth. Cataloguing all of life so that we can understand it, so we can look after it well, and preserve it.”

"It's a combination of large-scale epidemiology and large-scale genomics that haven't been married together in this way before"
- Sir Michael Stratton, talking to CNN in 2018

Sir Michael Stratton – Awards and recognition

For such a prominent figure in his field, it is little surprise that Sir Stratton has been recognised by some of the highest authorities in the world.

In 1999, he was elected a Fellow of the Academy of Medical Sciences – an independent body dedicated to advancing biomedical and health research.

Then in 2008, he was inducted as a Fellow of the Royal Society – a Fellowship of many of the world’s most eminent scientists and the oldest scientific academy in continuous existence.


In 2010 – the same year he was appointed Director of the Sanger Institute – he was awarded the Lila Gruber Award for Cancer Research.

This was followed in 2013 by the highest honour of them all, a knighthood in the Queen’s Birthday Honours for services to medical science.

On receiving his knighthood, he said: “I am thrilled and surprised to be honoured in this way… Our research to understand the changes in DNA that drive cancer is a partnership of scientists, clinicians, sponsors and patients. We work in the knowledge that incorporating discoveries from cancer genomes into clinical practice is already improving the diagnosis, prevention and treatment of cancer, with much more to come.”

Sir Michael Stratton receiving the In Search of Wonder Lifetime Achievement Award from Mario and Jean Prelorenzo of JDJ Creative

How is this related to In Search of Wonder®?

In Search of Wonder® is a celebration of those people who have dedicated their lives to wonder, either through participation or facilitation. Throughout his lifelong career in the field of cancer genetics, Sir Stratton has been focused on understanding our world and changing it for the better. This is dedication is the epitome of our campaign.

Earlier this year, Stratton announced his decision to step down as director of the Wellcome Sanger Institute and CEO of the Wellcome Genome Campus. This makes this a wonderful juncture at which to celebrate his achievements through the In Search of Wonder Lifetime Achievement Award.


Image Credit: PM visits Wellcome Genome Campus” (CC BY-NC-ND 2.0) by UK Prime Minister

Related Posts

Company News

JDJ sponsors
Science and
Tech award

Read article

Company News

2021: A year
in design

Read article

Company News

Brands we’ve
worked with who
are changing
the world

Read article

Company News

What‌ ‌we‌ ‌
learned‌ ‌from‌ ‌
redesigning‌ ‌
our‌ ‌own‌ ‌
website‌ ‌

Read article

Company News

Welcome to
our new-look

Read article

Company News

10 years
of JDJ

Read article

Company News

A decade of

Read article

Company News

colour book

Read article

Get in touch

We’re always keen to hear from like-minded people with passion and purpose,
so let’s see if together we can bring your vision to life.